Concurrent use of capecitabine with radiation therapy and survival in breast cancer (BC) after neoadjuvant chemotherapy.
Y L LiuC ChinB CataneseS M LeeS ZhanK KalinskyEileen P ConnollyPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2018)
Concurrent capecitabine/RT after NAC is associated with worse survival and should be carefully considered in BC.